Heart-Saving hope: melatonin and vitamin d tested in breast cancer patients
NCT ID NCT07349459
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether melatonin or vitamin D can help prevent heart damage in breast cancer patients receiving the chemotherapy drug doxorubicin. About 90 women will be randomly assigned to take melatonin, vitamin D, or a placebo alongside their cancer treatment. The goal is to see if these supplements reduce the risk of heart problems caused by doxorubicin.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DOXORUBICIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tanta University
Tanta, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••